Slide 1: Hydrix: improve a billion lives
hudrix™ improve a billion lives
Slide 2: Sales & Distribution, Product Innovation, Venture Investment
Sales & Distribution For personal use only Identifying and Growth through medtech innovation distributing high growth medtech products Product Innovation Transforming ideas into commercial products Venture Investment Investing in early-stage high potential medical device companies 2 29 October 2021
Slide 3: Our strategic focus: CVD is the No 1 cause of death globally
For personal use only No 1 CVD is the Our strategic focus Cause of death globally USD 18million 85% $1 trillion est Annual global CVD deaths Cost and CVD related caused by burden to deaths 1 heart attacks government or stroke 1 and hospitals 2 (1) World Health Organisation June 2021 3 29 October 202
Slide 4: Key CVD markets include $70-80B
Key CVD markets include $70-80B Ambulatory Interventional For personal use only Monitoring Devices3 Devices4 $3.8B $17.5B Estimated 2027 2025 objective Global market Global market Three or more 2020 2020 CVD devices $43.6B Estimated 2027 Estimated 2027 producing Global market 2020 $6.7B $26.8B +$50m
Slide 5: Preparing for product launches in CVD market in CY22
For personal use only Realising our objective Product 1 Product 2 Preparing for Implantable Monitoring Device Cardiovascular Surgery Device product AngelMed Guardian Phyzhon FFR FDA approved implantable Coronary guidewire with launches in continuous heart monitor integrated pressure sensor CVD marke
Slide 6: News flow: progressing towards first commercial product sales
For personal use only News flow Despite COVID causing ‘months’ of delays during the past 12 months we are progressing towards significant key milestones in the coming months Progressing towards first • Appoint additional Non-Executive Director (announced October 26) commercial • First AngelMed Guard
Slide 7: Driving value creation: changing the mix of Hydrix revenues
For personal use only Product Sales Driving value creation Fast emerging global medtech Investment product Returns company Design Services 2021 2025 Changing the mix of Hydrix revenues 7 29 October 2021
Slide 8: Summary
For personal use only Summary World class Products Board team sales into the and focused on US $70B management improving CVD market with a a billion commencing proven lives CY2022 track record 8 29 October 2021
Slide 9: For personal use only
For personal use only
Slide 10: Disclaimer
For personal use only This presentation has been prepared by Hydrix Limited (the “Company” or “Hydrix”). This presentation is being provided to investors for the sole purpose of providing preliminary background financial and other information to enable recipients to review the business activities of